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Type XIV collagen belongs to the subclass of fibril-associated 
collagens with interrupted triple helices, which are com-
posed of alternative triple helical and non-collagenous do-
mains. Structural data show that these molecules interact 
with collagen fibrils and suggest that they might interact 
with cells. We have investigated the expression of type XIV 
collagen in bovine skin during development. Fetuses from 9 
to 37 weeks were examined. Anti - type XIV collagen mono-
clonal antibody was produced, characterized, and used for 
immunofluorescence detection of the molecule. The localiza-
tion of immunolabeling was analyzed by comparison with 
light and electron microscopic observations. In 9-week - old 
fetus, no type XIV collagen was found in the skin. From 19 
weeks to birth, extensive immunofluorescence was observed 
on bundles of collagen fibrils in deep dermis. As shown by 
electron microscopy, this area exhibited bundles of collagen 
fibrils and cells with an abundant rough endoplasmic reticu-
T he collagen family of proteins comprises some 15 members [1 J; the functions for several of them are not yet clearly understood. The newly described type XIV collagen [2,3] belongs to a subclass with unique structural characteristics, named the FACIT group 
(fibril-associated collagens with interrupted triple helices) by Olsen 
[4]. Three FACIT collagens are known at present, types IX, XII, 
and XIV, the best characterized being type IX collagen, associated 
with type II collagen fibrils [5,6]. Immunostaining with a monoclo-
nal antibody specific for type XII collagen demonstrated that these 
molecules are associated with type I collagen fibrils in certain dense 
connective tissues such as tendons, ligaments, and perichondrium 
[7). A distinct but closely related molecule, type XIV collagen, was 
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lum. In the upper dermis, a delicate fibrillar network of type 
XIV collagen was revealed by immunofluorescence around 
growing hair follicles at 19 and 24 weeks. Double labeling 
(or type XIV collagen and fibronectin shows a more re-
stricted pattern of expression of type XIV collagen in this 
area. The electron microscopic examination of skin of fetuses 
at these stages shows that the whole upper dermis is com-
posed by a loose connective tissue containing scattered small 
bundles of collagen fibrils. Type XIV collagen was synthe-
sized in the upper dermis between 24 weeks and birth. From 
this study, it appears that type XIV collagen expression is 
distinct from that of fibrillar collagens, at least during some 
developmental events. The prominent localization of type 
XIV collagen around growing hair follicles suggests a role 
(or this molecule in epithelial-mesenchymal interactions. 
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isolated from type I coJlagen-containing tissues such as skin and 
tendons [2,3). Considering the association of FA CIT collagens with 
collagen fibrils and assuming that the organization of type IX colla-
gen at the surface of fibrils [8J as a general scheme, it has frequentl y 
been postulated that the FACIT collagens constitute molecular 
bridges, linking together the fibrils of a tissue [9,10). The generaliza-
tion of this organization has been strongly supported by the im-
munolocalization of two collagen molecules related to type XII [11] 
at the surface of collagen fibrils [12) . However, an additional func-
tion of at least some of the FACIT coJlagellS in cell-matrix interac-
tions has been suggested by the knowledge of the complete primary 
structure of chicken type XII collagen; a cDNA analysis of this 
collagen has revealed a complex succession of protein motifs (fibro-
nectin type III, von Willebrand factor A) in the non-helical amino-
terminal end, and an arginin-glycin-aspartic acid (RGD) potential 
cell recognition adhesive sequence in a helical domain [13]. A simi-
lar modular structure was recently described for type XIV collagen 
[14J. These structural data indicate that these molecules may inter-
act with other matrix components and with matrix receptors 
present on cell surfaces. One approach for revealing the functions of 
such molecules is to study their developmental expression. With 
this prospect, using a monoclonal antibody specific to bovine type 
XIV collagen obtained in the laboratory, we have investigated the 
localization of this FACIT collagen in various stages of fetal bovine 
skin. 
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MATERIALS AND METHODS 
Reagents Unless otherwise specified, chemicals were purchased 
from Sigma (St Louis, MO) and tissue culture reagents from Gibco 
Laboratories (UK). 
Antigen Preparation Bovine type XII and type XIV collagens 
were purified respectively from tendon and skin of 6-month - old 
fe tuses following a previously described procedure [15] . Briefly, 
tissues were first extracted with 0.25 M NaCI. The resulting extract 
was submitted to carboxymethyl (CM) -cellulose chromatography 
and further purified by chromatography on Con A - sepharose. Dif-
ferentia l elution of type XIV and type XII collagens was achieved 
respectively with a-methyl mannoside and a-methylglucopyrano-
side. 
Immunization A five-week-old female Balb/c mouse was im-
munized with bovine type XIV collagen purified from skin. Ten 
micrograms of antigen emulsified in complete Freund's adj uvant 
were injected subcutaneously at multiple sites. Booster injections 
were given 3 and 5 weeks later with the same dose in incomplete 
adjuvant. Intraperitoneal boosts with antigen in Con A elution 
buffer were done 8 and 1 d before fusion . 
Monoclonal Antibody Production The methods for fusion 
and establishment of antibody-producing hybridomas followed the 
procedures described by Linsenmayer and Hendrix [16] . The mouse 
was sacrificed by cervical dislocation and the spleen was removed 
aseptically. The resulting cell suspension was fused with sp2/0 Ag 
14 myeloma with polyethyleneglycol4000 at a ratio of three splen-
ocytes to one myeloma eel!. After fusion, the cells were dispersed 
into 96-well plates. Antibody secretion was screened by enzyme-
linked immunosorbent assay (ELISA) (see above) against purified 
type XIV collagen (O.l lLg/well). Positive hybridomas were cloned 
twice by the method of limiting dilution. Hybridoma culture me-
dium was composed of RPMI supplemented with 1 mM pyruvate, 
2 rnM glutamine, 100 U/ml penicillin, 100 ILg/ml streptomycin, 
100 ILg/ml glucose, 0.05 mM mercaptoethanol, 10 mM (HEPES), 
(N-[2-hydroxyethyl]piperazine-N'-2-ethanesulfonic acid (HEPES), 
and 10% fetal calf serum. 
Elisa For screening anti - type XIV collagen producing hybrid-
omas, and for subsequent testing of antibody specificity, an ELISA 
technique was used. Polystyrene micro titer plates (Greiner, France) 
were coated with 100 ILl of antigen diluted in phosphate-buffered 
saline (PBS) and dried under vacuum (RC 10-01, Jouan, France). 
Non-specific sites were blocked with 1 % bovine serum albumin 
(BSA), 0.05% Tween 20 in PBS. The antibody to be tested was 
diluted if necessary in the blocking solution, added to the wells for 
1 h, and rinsed with 0.05% Tween in PBS. Wells were incubated in 
peroxidase-conjugated anti-mouse Ig (Dakopatts, Denmark) and 
rinsed. The amount of bound enzyme was measured with 2,2'-
azino-di(3-ethyl-benzthiazoline sulphonate) (ABTS) and the ab-
sorbance read at 405 nm (SL T Instruments microplate photometer). 
Characterization of Monoclonal Antibodies by Immuno-
blotting A crude preparation containing type XIV collagen was 
obtained by extracting bovine skin with 0.25 M NaCI in the J;>res-
ence of protease inhibitors, according to Aubert-Foucher et allIS]. 
The final protein concentration of this extract was approximately 1 
mg/m!. For disulfide bond reduction, samples were treated with 
2 mM dithiothreitol. After denaturation (3 min at 100°C), optional 
alkylation with 0.2 M iodoacetamide was performed 1 h in the 
dark. The extracts were then dialyzed for 24 h at 4 ° C against colla-
genase buffer (20 mM Tris, pH 7.6; 0.2 M NaCI; 5 mM CaCI2). 
Some samples were treated with collagenase (Advanced Biofacture) 
at 250 U /m!. An equivalent volume of buffer was added in controls . 
Digestion was carried out for 24 h at 37"C. 
SDS-PAGE was performed in Mini-Protean II system (BioRad) 
according to Laemmli [17]. Sample buffer (5 X concentrated) was 
added to the 0.25 M NaCI extracts and boiled for 3 min. Five 
microliters of extract were loaded on 6% acrylamide gels and trans-
ferred electrophoretically to immobilon membrane (Millipore) in 
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10 mM (3-[cyclohexylamino]-I-propanesulfonic acid CAPS), pH 
11,5% methanol for 5 hat 60 V. 
The membrane was treated with 10% low-fat dried milk in PBS, 
incubated with antibodies (hybridoma supernatant diluted 1 : 100 in 
Tween-PBS) for 1 h, and rinsed . The primary antibody was de-
tected with anti-mouse Ig conjugated with alkaline phosphatase 
(Dakopatts, Denmark) diluted 1/1500 and rinsed in PBS. The 
membrane was treated with an alkaline-phosphatase detection kit 
(BioRad), rinsed in water, and dried. 
Tissue Specimens Fetal bovine skins were obtained from the 
local slaughterhouse within 2 h after death. Age of fetuses was 
estimated with the femoral or tibial length, according to Pal et at 
[18]. 
Immunofluorescence Samples were embedded in OCT com-
pound (Miles Scientific, Naperville, IL), frozen in liquid nitrogen, 
and stored at -70°C. Sections (61Lm thick) made with a cryostat 
were harvested on aminoalkylsilane-treated slides [19] and air-
dried. 
After incubation in 1 % bovine serum albumin (BSA) in PBS, the 
primary antibody (hybridoma supernatant) was added in concentra-
tions ranging from undiluted to 320-times dilution. Immunoglobu-
lins fixed to the antigen were recognized with anti-mouse IgG 
conjugated to fluorescein isothiocyanate (FITC) - diluted 1: 400 
(Biosys, France). For double-labeling experiments, the second anti-
gen was detected by polyclonal rabbit anti-human type IV collagen, 
anti-bovine type I collagen, or anti-human fibronectin (lgG frac-
tions), diluted 1: 100 (Institut Pasteur, Lyon, France) and revealed 
by rhodamine-linked anti-rabbit IgG diluted 1 : 100 (Nordic Immu-
nology, The Nederlands). Antibodies and conjugates were diluted 
in 1 % BSA in PBS. Slides were mounted in glyceroljPBS and exam-
ined with a Zeiss Universal microscope equipped with epifluores-
cence. As control, specific antibodies were replaced by purified non-
immune mouse IgG (Biosys, France) diluted at 50 ILg/ml in 
hybridoma culture medium or by normal rabbit serum. 
To locate more precisely the immunolabeling, some cryosections 
were stained with 1 % toluidine blue, dried, mounted, and observed 
with a Leitz light microscope. 
Light and Transmission Electron Microscopy After Epon 
Embedding Skin samples were fixed in 2% glutaraldehyde in 
PBS for 3 h at room temperature and rinsed in PBS overnight. 
Post-fixation was performed during 1 h in 1 % osmium tetroxide in 
PBS. Tissues were then dehydrated in graded ethanol solutions and 
embedded in Epon 812. Sections were obtained using a Reichert-
Jung Ultracut microtome. 
Semi-thin sections were mounted on glass slides, stained with 
methylene blue-azur II, and photographed with a Leitz light micro-
scope. 
Thin sections were contrasted with methanolic uranyl acetate 
and lead citrate. Grids were examined with aJeol1200EX electron 
microscope at the Centre de Microscopie Electronique Appliquee a 
la Biologie et a la Geologie (Claude Bernard University, Villeur-
banne, France) . 
RESULTS 
Specificity of Monoclonal Antibody to Type XIV Col-
lagen The monoclonal antibody used in this study displayed sig-
nificant reactivity in ELISA with purified type XIV collagen, with a 
titer of 5 X 103 for hybridoma culture supernatant (Fig lA). Under 
the same conditions, type XII collagen, a closely related molecule, 
was not detected. Other extracellular matrix molecules such as fibro-
nectin and type I collagen were not recognized (Fig lA). Using a 
crude preparation, 0.25 M NaCI skin extract, we showed that on 
immunoblots after sodium dodecylsulfate - polyacrylamide gel elec-
trophoresis the pattern of the antibody's reactivity is consistent with 
the electrophoretic characteristics of type XIV collagen (Fig IB). 
Under non-reducing conditions, high - molecular-mass compo-
nents are recognized: the bands are located at the upper limit of the 
6% polyacrylamide separating gel. After reduction, the two charac-
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Figure 1. Charac terization of the monoclonal antibody CY15B8. (A) Ti-
tration curves of hybridoma culture supernatant. Plates were coated with 
5 ng of antigen per well and the reactivity measured by ELISA as described in 
Materials and Methods. Antigens used were bovine type XIV collagen (11), 
type XII collagen (.), type I collagen (.6), and fibronectin (0). 
(B) Immunoblot against 0.25 M NaCI skin extract separated on 6% polyac-
rylamide gel. The CY 15D8 hybridoma culture supernatant was diluted 
1 : 100. LaJle 1, unreduced sample; lalle 2, same as in laJlc 1, after treatment 
with collagenase; latle 3, reduced sample; lalle 4, reduced and alkylated sam-
ple; lane 5, same as in Jane 4, treated with collagenase. 
teristic bands of type XIV collagen, at 220 and 290 kDa, are labeled. 
Additional alkylation with iodoacetamide causes the appearance of 
one unique band at 220 kDa. This observation is consistent with the 
previous demonstration of one cryl?tic disulfide bond between two 
alpha chains of type XIV collagen [lS]. After digestion with colla-
genase, the antibody reacts with a band at 190 kDa, indicating that 
its epitope is located in the NC3 domain of type XIV collagen. 
Sites of Type XIV Collagen Expression In a 9-week-old bo-
vine fetus, type XIV collagen was clearly detected in large bundles 
of collagen fibrils in tendons (Fig 2A), whereas it could not be 
detected in the skin (Fig 2B) at this stage. 
In a 19~week - old fetus, type XIV col1agen was evident in the 
skin. In the deep dermis, a faint staining was observed on large 
bundles of collagen fibrils (Fig 3A,B,D) and intracellular accumula-
tions were regularly noticed (Fig 3B). In the upper dermis, the 
detection of type XIV collagen was restricted to the junctional area 
between dermis and epidermis. It was noticeable around the grow-
ing hair follicles (Fig 3A,F), where it formed basket-like structures 
(Fig 3C). Occasionally, type XIV collagen was detected in perineu-
rium and endoneurium of nerve endings (Fig 3D). Double-labeling 
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Figure 2. Type XIV collagen localization in 9-week - old bovine fetus. I~ 
tendon (AJ bundles of co llagen fibers display a good reactivity, whereas ~ 
skin (B) labeling is undetectable. Bar, 50 j.lm. 
with anti - type IV and anti - type XIV collagen antibodies showed. 
their distinct organization in the upper dermis. Type IV collagen, 
was detected at the level of basement membranes, beneath the epi, 
dermis, and around the hair follicles (Fig 3E). Type XIV collagel\ 
was not distinctly associated with the dermal-epidermal basement 
membrane, but was found underneath it and associated with the 
collagen bundles surrounding hair follicles (Fig 3F). This general 
distribution of type XIV collagen was retained and enhanced in th~ 
skin of fetuses of 22 weeks (Fig 4A), 24 weeks (Fig SA,B), and 27 
weeks (not shown). 
To correlate the expression of type XIV collagen with the struc, 
ture of bovine developing skin, we performed immunolabeling, am! 
light and electron microscopy OJ] the same skin sample, obtaine~ 
from a 22-week - old fetus (Fig 4). Low-magnification immunoflu'h 
rescence (Fig 4A) showed that the deep dermis is extensively la, 
bel ed, compared to the underlying loose connective tissue. Thi1 
localization of labeling in deep dermis was confirmed by the obser, 
vation of stained cryosections (Fig 4B), where condensation of mes, 
enchymal cel1s was observed in this area. By observation of semi\ 
thin sections (Fig 4C), we have investigated the structure at 
developing skin at a higher resolution. Budding hair follicles we~ 
surrounded by condensations of dermal cells and the upper dermi\ 
was composed of relatively loose connective tissue, compared to, 
deep dermis in which bundles of collagen fibrils and fibroblasti~ 
cells were clearly identified. By electron microscopy, deep dermi\ 
appeared composed of large bundles of collagen fibrils (50 tI\ 
100 nm in diameter) and cells containing extended rough endoplas, 
mic reticulum profiles (Fig 4D). In the upper dermis, we founq 
sparse small bundles of collagen fibrils (smaller than 50 11m in diam, 
eter) and restrained rough endoplasmic reticulum in cells (Fig 4£), 
Around elongated hair follicles, in the area corresponding to th~ 
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Figure 3. Type XIV collagen localization in 19-week - old bovine fetal skin. Deep dermis and budding hair follicl es are intensely labeled (A) . In deep dermis, 
type XIV is present on bundles of collagen fibers and in intrace llular vesicles (B), and in perineurium and endoneurium (D). In hair follicles, fluorescence 
appears as a fibrill ar nerwork (C). Double immunolabeling of t 9-week - old fetal skin (E and F). Anti - type IV collagen antibodies were revealed by rhodamine 
(E) and anti-type XIV collagen antibody by FITC (F). The rwo molecules exhibit distinct localizations in the upper dermis. Bar, 50 f.lm. 
localization of type XIV collagen, small bundles of collagen fibrils 
were observed, beneath keratinocyte basement membrane (Fig 4F). 
Double-labeling experiments, performed on sections of skin 
from a 24-week-old fetus showed a distribution of type XIV colla-
gen (Fig SA,B) distinct from that of type I collagen (Fig SC), and 
from the distribution of fibronectin (Fig SD). Type I collagen was 
uniformly distributed in the whole dermis (Fig SC), whereas fibro-
nectin was concentrated in the upper dermis including the 
surroundings of hair follicles and blood vessels (Fig SC). Electron 
microscope observations performed on this skin sample showed a 
structure similar to that observed at 22 weeks (Fig SE,F). However, 
in deep dermis (Fig SE) and around hair follicl es (Fig SF), the 
bundles of collagen fibrils were larger in size. 
The concentration of type XIV coll agen around the hair follicles 
appeared to vary according to the developmental stage considered. 
At 19 weeks, the hair follicles were formed and the type XIV locali-
zation was almost uniform (Fig 3C). At later stages, type XIV colla-
gen appeared more concentrated in the sheath around the hair folli-
cles (Fig SA). At 37 weeks, just before birth, type XIV collagen 
immunolabeling was intense and its distribution was uniform in the 
whole derrnis (Fig 6A,B) . 
DISCUSSION 
The normal embryonic development of a large number of organs is 
controlled by the reciprocal interactions of their epithelial and mes-
enchymal components [20 -22]. This multistep inductive process 
has been particularly documented during the early development of 
skin appendages (hairs, feathers , and scales), teeth, and branched 
organs (lung, salivary, and mammary glands). The basement mem-
brane, located at the epithelial-mesenchymal interface, has been 
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Figure 4. Structure and labeling of 22-week - old fetal skin. Immunofluorescence of type XIV collagen (AJ is positive aroUltd budding hair follicles and in 
deep dermis. Hypodermal loose connective tissue is faintly labeled. On stained cryosections (B), accumulation of mesenchymal cells is observed in the whol~ 
dermis. On semi-thin sections obtained after Epon embedding (C), the budding hair follicles are surrounded by dermal cells accumulation and bundles of 
collagen fibrils and fibroblastic cells are found in deep dermis. Spotted areas in e correspond to the respective positions in D, E, and F. As seen in transmission 
electron microscopy (D, E, and F), deep dermis cells exhibit a distended rough endoplasmic reticulum; the visible collagen fibrils are 50 to 100 nm in diameter 
(D). In the loose connective tissue of upper dermis small bundles of thin fibrils «50 nm) are observed (E). Similar fibrils are found below basement 
membrane, around growing hair foHicles (F) . Bars: A and B, 100 J4.1l1; e, 50 JLIn; D and E. 2 JLIn; F, 0.5 JLIn. 
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Figure 5. Double immunolabeling and electron microscopy of 24-week - old fetal skin. Deep dermis and the sheath of hair follicles are labeled (A). 
Enlargement of these follicles shows a filamentous organization of type XIV collagen (B). ( A, e) Double immunolabeling for type XIV collagen (A) and type 
I collagen (e). Type I collagen is equally distributed in this tissue. Immunolabeling for fibronectin (D) shows that its expression is restricted to the upper 
dermis, with a prominent localization around hair follicles and blood vessels. By electron microscopy, deep dermis is composed oflarge bundles of collagen 
fibrils (E) whereas closely packed thin collagen fibrils are observed around budding hair follicles (F). Bars: A, B, e, and D, 50 lim; E and F, 2 lim. 
considered in the mediation of tissue interactions as stabilizing the 
epithelial differentiation [23] . Several extraceHular matrix compon-
ents are involved during such interactions. Laminin promotes cell 
growth during lung morphogenesis [24]. Tenascin, a large, six-
armed chimeric molecule modulating cell-matrix adhesion [25], is 
transiently expressed during the development of feather buds [26], 
hair foHicles [27], and scales [28]. Syndecan, a ceH surface proteogly-
can, is expressed during tooth embryogenesis [29,30]. During 
branching morphogenesis, the remodeling of the basement mem-
brane is controlled by mesenchyme, which degrades glycosamino-
glycans [31] . Collagen fibrils are involved in the stabilization of 
basement membrane in the interlobular clefts of these branched 
organs [32,33] . During the development of cutaneous appendages, 
coHagen is usually found in stable areas, whereas fibronectin is lo-
cated in morphogenetic zones [34,35]. Our results concern a colla-
gen molecule that is thought to be associated with collagen fibrils 
and consequently could be the actual molecule involved when cells 
interact in lIillo with bundles of collagen fibrils. 
The previously described procedure of collagen preparation 
clearly separates type XII and type XIV collagens [15]. The antigen 
used for monoclonal antibody production was strictly identified as 
type XIV collagen by protein sequencing. Our antibody, CY 15 E8, 
recognizes type XIV collagen bands separated by electrophoresis, 
and, after collagenase digestion, binds to a sub-band corresponding 
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Figure 6. Type XIV collagen localization in 37-week - old fetal skin. The 
molecule is present in the whole matrix of upper dermis (AJ and in area of 
the deeper dermis (B). Bars, 50 pm. 
to the amino-terininal NC3 domain. It does not cross-react with 
type XII collagen, type I collagen, and fibronecrin. With this 
narrow specificity and its high ELrSA titer, this antibody appears to 
be a va luable tool for immunofluorescence study of type XIV colla-
gen expression. 
The expression of rype XIV collagen in bovine embryonic skin is 
a late and sequentia l event. At 9 weeks of development, type XIV 
collagen was not detected in the who le skin, whereas it was clearly 
visible in tendons. It appeared first in the deep,. reticular dermis and 
around fonning hair follicles and was synthesIzed throughout the 
dermis just before birth. Its distribution is distinctly different from 
that of type I collagen and fibronectin. Comparing our results with 
the data obtained by Lunstrum et at [11 J, the localization of rype 
XIV collagen is similar to the localization of the type XII-like B 
molecule. Very recently, these authors have confirmed by peptide-
sequencing studies that rype XII -like B collagen is in fact rype XIV 
collagen [36]. Additionally, the accumulation of intracellular type 
XIV collagen strongly suggests a massive gene expression in dermal 
cells, at least at certain stages of development. This observation is 
consistent with electron microscope data. Indeed in deep dermis 
during development, cells exhibit a prominent distended rough 
endoplasmic reticulum, indicating a high level of protein synthesis. 
As shown by comparison of immunofluorescent and stained cryo-
sections, this deposition of rype XIV coll agen in skin is concomitant 
with the differenciation of deep dermis in relation to the underlying 
loose connective tissue. Also at this stage, we observed a marked 
difference in the labeling of deep and upper dermis. Assuming that 
bovine and human gestational periods are similar (274 and 252 d, 
respectively), these differences cou ld be correlated with the distinc-
tion of reticular and papillary dermis that became possible at 4 
months in human embryo [37]. It should be emphasized that this 
elaboration of rype XIV collagen is associated with large bundles of 
type I collagen fibrils, suggesting that it could be involved in the 
stabilization of extracellular matrix in this area. 
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Outing differentiation of embryonic dermis, collagen fibrils ap, 
pear early in the extracellular matrix, even before the budding ot 
hair follicles. These fibrils are visible by 5 weeks in the huma1\ 
embryo [37]. We confirmed this observation on 18-week-old bo, 
vine skin, where hair follicles are not formed; the dermis is mainly 
cel lular, but contains small bundles of collagen fibrils (data no~ 
shown). At 22 and 24 weeks in our model, we found numero~ 
collagen fibrils in the upper dermis. These fibrils exhibit the samt) 
diameter, all around hair follicles, in interfollicular dermis, wherea~ 
type XIV collagen is preferentiall y deposited around hair follicles. 
Thus, there is apparently no relationship between the size of colla_ 
gen fibrils and the presence of type XIV collagen. 
The specific localization of type XIV collagen around developing 
hair follicle strongly suggests a function of this protein during the 
formation of skin appendages. Interactions between epidermis and 
dermis are essential for hair follicle initiation and development [38). 
The prominent location of type XIV collagen in developing hair 
follicle mesenchyme is particularly significant in this respect. The 
molecular composition of extracellular matrix is thought to play an 
imJortant role in epidermal-mesenchymal interactions. Mauger et 
al l35} reported during hair development of mouse skin an heteroge-
neous distribution of type I, rype III collagens, and fibronectin: 
collagens became sparse around hair buds and fibronectin was partic-
ularly abundant along the dermal-epidermal junction of hair rudi-
ments as well as underneath hair buds. In the bovine model, type I 
collagen was found uniformly throughout dermis during the for-
mation of hair follicle . Similar results were obtained for type In 
collagen (data not shown). In our system, the presence of fibrillar 
collagen seems not related to stabilized zones. Small bundles ot 
collagen fibrils in this area could be sufficiently loose to allow mOr-
phogenetic movements. Fibronectin expression during bovine skin 
development is similar to that observed in mouse; this molecule is 
abundant in morphogenetically active zones and mostlikely contrib-
utes to cell migration. Fibronectin accumulation around blood ves-
sels is consistent with the previous results of Tonnensen et al [39}, 
who observed fibronectin expression during the development of (he 
microvasculature in human skin. 
During the invagination of epithel ial cells forming the haiI folli-
cle, the underlying extracel lular matrix is probably a site of exten-
sive turnover. Tissue inhibitor of metalloproteinases (TIMP) gene 
expression in the sheath offollicle that form vibrissae [401 is signifi-
cant in this respect. Reponen el al [41] have shown that epithelial 
cells from the hair follicle express the 72-kDa type IV collagenase. 
In this situation, it could be postulated that keratinocytes may lo-
cally interact with dermal connective tissue, considering that the 
basement membrane is constantly remodeled. The restricted distri-
bution of tenascin was described in this area [27,42]. It has been 
shown that ill vitro, this molecule can modulate the behavior of cells 
by preventing adhesion to fibronectin [43]. The migration of a 
human keratinocyte cell line on interstitial collagen rype 1 has been 
established and characterized ill vitro [44]. Considering the associa-
tion of type XIV collagen with collagen fibrils, it is tempting to 
hypothesize that type XIV coll agen might prevent also the interac-
tion of cells with fibrillar collagen. Finally, during the morphogen-
esis of hair follicles, rype XIV collagen might have a dual function: 
1) the limitation of keratinocyte migration by the partial stabiliza-
tion oElocal extracellular matrix and 2) the lowering ofkeratinocyte 
attachment to collagen to promote morphogenetic movements. III 
vitro studies using cells isolated from skin would be helpful in the 
complete understanding of this phenomenon. 
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